Virtu Financial LLC Spring Works Therapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$18.36 - $60.07 $101,402 - $331,766
5,523 Added 114.92%
10,329 $254,000
Q1 2022

May 17, 2022
SELL
$48.97 - $65.46 $40,449 - $54,069
-826 Reduced 14.67%
4,806 $271,000
Q4 2021

Feb 17, 2022
BUY
$53.3 - $75.84 $300,185 - $427,130
5,632 New
5,632 $349,000

Others Institutions Holding SWTX

# of Institutions
238
Shares Held
69.8M
Call Options Held
144K
Put Options Held
257K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.43B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email